CL4 is a specifically designed to target the Epidermal Growth Factor Receptor (EGFR) . EGFR is a protein often found in high amounts on the surface of certain cancer cells, such as those in triple-negative breast cancer (TNBC) and non-small cell lung cancer (NSCLC) . In laboratory research, CL4 has shown promise by: Binding specifically to cancer cells that overexpress EGFR.
Because CL4 is still in the , you cannot buy it at a pharmacy or through standard medical providers. where to buy cl4 for cancer
It is common to confuse "CL4" with (Cytotoxic T-Lymphocyte Antigen 4). Unlike the experimental CL4 aptamer, CTLA-4 inhibitors are a well-established class of FDA-approved immunotherapy. CL4 is a specifically designed to target the
: CL4 is available through specialized biotechnology suppliers and molecular tool laboratories (such as Quality4Lab ) exclusively for in vitro and in vivo laboratory research. Because CL4 is still in the , you